000			01361 a2200361 4500
005			20250514050935.0
264		0	_c20021204
008			200212s 0 0 eng d
022			_a1097-6256
024	7		_a10.1038/nn941 _2doi
040			_aNLM _beng _cNLM
100	1		_aDawson, Ted M
245	0	0	_aNeuroprotective and neurorestorative strategies for Parkinson's disease. _h[electronic resource]
260			_bNature neuroscience _cNov 2002
300			_a1058-61 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xpharmacology
650	0	4	_aBrain _xdrug effects
650	0	4	_aCalcium-Binding Proteins
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Design
650	0	4	_aHumans
650	0	4	_aMembrane Proteins _xdrug effects
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aMuscle Proteins _xdrug effects
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aParkinson Disease _xmetabolism
650	0	4	_aRecovery of Function _xdrug effects
700	1		_aDawson, Valina L
773	0		_tNature neuroscience _gvol. 5 Suppl _gp. 1058-61
856	4	0	_uhttps://doi.org/10.1038/nn941 _zAvailable from publisher's website
999			_c12212388 _d12212388